Sentence examples for low levels of efficacy from inspiring English sources

Our findings demonstrate that flood-risk preparedness can be undermined by low levels of efficacy amongst individuals in terms of the preparedness measures available to them and their own personal capacity to implement them.

While the transition from one institution to another can be problematic for young people, such as for students entering secondary schools in the UK (Sodha and Guglielmi [2009]) or the many American high school students who arrive 'with low levels of efficacy and self-worth' (Kelly and Price [2009], 810), a major focus often falls on 14-16-year-olds 14-16-year-olds 14-16-year-olds 14-16-year-olds

Likewise, newer anthracyclines such as epirubicin, detorubicin, pirarubicin and mitoxantrone have shown low levels of efficacy and have offered no clinically relevant advantage over doxorubicin (Colbert et al, 1985; Eisenhauer et al, 1986; Sridhar et al, 1989; Kaukel et al, 1990; Magri et al, 1991; van Breukelen et al, 1991; Mattson et al, 1992; Magri et al, 1992).

Although the efficacy of pre-pandemic vaccine remains uncertain, pre-pandemic vaccination should still be useful even at a low level of efficacy [27].

The answer to this question is unclear: the delay in healing associated with systematic disinfection and the very low level of efficacy observed do not favour this practice [ 19].

However, the study was also able to show that these companies have a high outcome expectation with respect to WHP and that it can be utilized as a resource for improving a low level of efficacy expectation or for increasing WHP willingness at the management level.

Among these discarded agents are bifunctional alkylators and platinum salts, which are not commonly used, with the exception of cyclophosphamide (Endoxan; Baxter International, Deefield, IL, USA), due to their relatively high toxicity and low level of efficacy in unselected breast cancer patients [ 2– 5].

This finding is consistent with research findings based on other health threats which indicates that low levels of self efficacy and response efficacy provide a barrier to action [ 11, 12].

Low levels of transfection efficacy and lipid-associated cytotoxicity have complicated the use of cationic lipids to facilitate transfer of exogenous DNA to eukaryotic cells.

However, like other pharmacological monotherapies devised for the treatment of obesity, these strategies showed disappointingly low levels of clinical efficacy.

This limited awareness as well as low levels of genomic efficacy could impact patient-provider communication about PCa susceptibility testing.